Matt Miksic: Yeah, yeah, no, that’s helpful. And just, it sounds like we should expect those things to kind of continue behind those businesses into 2024, understanding that you’re not giving in…
Moshe Mizrahy: Absolutely. Absolutely. Don’t forget that the ophthalmology platforms were introduced in Canada, and now soft launch in the US, but we have not started in ROW, not in the other territories, we’re waiting.
Matt Miksic: Got it. Super helpful. And the follow up just is on, you’ve talked before about the competitive environment. Would love to get your an update as to sort of what you’re seeing, what you expect to see, if there’s demand, are you having to sort of fight for it any more or less than you did a year or two ago, any color you share there would be helpful.
Moshe Mizrahy: Shakil, I believe you should answer that.
Shakil Lakhani: Yeah, Moshe, I’m not sure, I think he has a connection problem, so I’ll handle that. In terms of competition, yeah, in terms of competition, yeah, I wouldn’t say it was ever easy or I don’t think it will ever be easy. And if that ever happens, I’m sure we’ll all be pretty happy about that. But, we’ve definitely, as I mentioned, in terms of us investing in brand awareness, things like that, it’s made it a little easier, I would say. And a lot of the competitors, they’re going to have different strategies and everyone’s going to continue to sell competition breeds awareness. So we’re of the philosophy that if everyone’s doing well in our business, it’s better for everybody, rather than taking a different approach trying to take down a giant, which a lot of the competitors try to do.
But that’s just — that’s not how we approach things. So from our perspective, the better the industry does, the better it is and we feel like consumer demand, but also coupled with position demand for the need to actually incorporate some of these technologies into their practices, for additional revenue, income, so on and so forth, is going to continue driving this business and, it’s on us to continue innovating and providing them with the appropriate tools and technology so that they’re able to do that and that’s going to differentiate things. We have a user meeting coming up in August in Chicago, and I think we have over 600 practices signed up every year. It’s great. We try to give them the ammunition that they need as part of their practices, along with our post-sale support team who’ve done an incredible job.
So our goal is, we try to equip our people with what they, our customers with what they need from a technology perspective, but also from a marketing perspective and how to help them be successful. We try our best at it. At least we can’t guarantee anything. But, as far as the competitive landscape goes, I think it’s pretty strong right now demand-wise. I don’t know if some of our competitors have made some of the changes that they may have needed to in terms of financing and how to handle that. But, we’re a few steps ahead, I believe.
Operator: The next question is from Caitlin Cronin with Canaccord Genuity. Please go ahead.
Caitlin Cronin: Hi, everyone. This is Kaitlyn on for Kyla Rose and congrats on a great quarter. Just a couple questions. Starting with Empower, how’s the continued launch going and any updates to expectations? And have you begun hiring any Empower-specific reps? And where are we from like an OUS launch and approval standpoint on that? And I have a follow-up?
